DK2297132T3 - Fremgangsmåde til fremstilling af et mellemprodukt af dabigatran-etexilat - Google Patents

Fremgangsmåde til fremstilling af et mellemprodukt af dabigatran-etexilat Download PDF

Info

Publication number
DK2297132T3
DK2297132T3 DK09765795.1T DK09765795T DK2297132T3 DK 2297132 T3 DK2297132 T3 DK 2297132T3 DK 09765795 T DK09765795 T DK 09765795T DK 2297132 T3 DK2297132 T3 DK 2297132T3
Authority
DK
Denmark
Prior art keywords
preparing
dabigatran etexilate
etexilate
dabigatran
Prior art date
Application number
DK09765795.1T
Other languages
English (en)
Inventor
Wolfgang Dersch
Christian Filser
Rainer Hamm
Arndt Hausherr
Gunter Koch
Ulrich Scholz
Georg Zerban
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39863126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2297132(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK2297132T3 publication Critical patent/DK2297132T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
DK09765795.1T 2008-06-16 2009-06-12 Fremgangsmåde til fremstilling af et mellemprodukt af dabigatran-etexilat DK2297132T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08158364 2008-06-16
PCT/EP2009/057266 WO2009153215A1 (de) 2008-06-16 2009-06-12 Verfahren zur herstellung eines zwischenprodukts von dabigatran etexilate

Publications (1)

Publication Number Publication Date
DK2297132T3 true DK2297132T3 (da) 2015-05-26

Family

ID=39863126

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09765795.1T DK2297132T3 (da) 2008-06-16 2009-06-12 Fremgangsmåde til fremstilling af et mellemprodukt af dabigatran-etexilat

Country Status (20)

Country Link
US (1) US8471033B2 (da)
EP (1) EP2297132B1 (da)
JP (1) JP5265003B2 (da)
KR (1) KR101677915B1 (da)
CN (1) CN102066355B (da)
AR (1) AR072143A1 (da)
AU (1) AU2009259440B2 (da)
BR (1) BRPI0914788B1 (da)
CA (1) CA2728058C (da)
CL (1) CL2010001442A1 (da)
DK (1) DK2297132T3 (da)
ES (1) ES2536728T3 (da)
HU (1) HUE025533T2 (da)
IL (1) IL208371A (da)
MX (1) MX2010013258A (da)
NZ (1) NZ588488A (da)
PL (1) PL2297132T3 (da)
RU (1) RU2524212C2 (da)
TW (1) TWI440635B (da)
WO (1) WO2009153215A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005061623A1 (de) 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
KR20100129281A (ko) * 2008-03-28 2010-12-08 베링거 인겔하임 인터내셔날 게엠베하 경구 투여되는 다비가트란 제형의 제조 방법
TWI436994B (zh) * 2008-07-14 2014-05-11 Boehringer Ingelheim Int 製備含有達比加群(dabigatran)之藥物組合物的新穎方法
EA201100756A1 (ru) 2008-11-11 2011-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Способ лечения или профилактики тромбоза с использованием этексилата дабигатрана или его соли с улучшенным профилем безопасности по сравнению со стандартным лечением варфарином
US8399678B2 (en) 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
WO2012077136A2 (en) * 2010-12-06 2012-06-14 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and its salts
HUP1100244A2 (hu) 2011-05-11 2012-11-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Gyógyszeripari intermedierek és eljárás elõállításukra
CN102633713B (zh) * 2012-03-22 2013-12-11 南京工业大学 达比加群酯中间体及其制备方法、以及制备达比加群酯的方法
US9273030B2 (en) 2012-04-02 2016-03-01 Msn Laboratories Private Limited Process for the preparation of benzimidazole derivatives and salts thereof
CN103420983B (zh) * 2012-05-24 2015-07-08 天津药物研究院 达比加群酯衍生物及其制备方法和用途
CN102850326B (zh) * 2012-06-19 2014-04-09 上海现代制药股份有限公司 一种达比加群酯中间体及其制备方法和应用
CN103772358A (zh) * 2014-01-07 2014-05-07 万特制药(海南)有限公司 一种制备达比加群酯的合成方法
CN104003977B (zh) * 2014-06-05 2016-04-13 雅本化学股份有限公司 N-(2-氯甲基-1-甲基-1h-苯并咪唑-5-酰基)-n-(吡啶-2-基) -3-氨基丙酸乙酯的制备方法
CN103992241B (zh) * 2014-06-05 2016-08-24 雅本化学股份有限公司 N-取代苯基甘氨酸的制备方法
CN105348148B (zh) * 2015-11-30 2017-12-26 山东新华制药股份有限公司 制备达比加群酯中间体缩合物的杂质的草酸盐的方法
CN109232535A (zh) * 2018-09-25 2019-01-18 重庆奥舍生物化工有限公司 一种非肽类凝血酶抑制剂达比加群酯的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19924818A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
EP1609784A1 (de) 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102005061624A1 (de) 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102005061623A1 (de) 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
EP1956018A1 (de) 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
CA2716642C (en) 2008-03-28 2017-02-28 Boehringer Ingelheim International Gmbh Method for manufacturing acid pellets
KR20100129281A (ko) 2008-03-28 2010-12-08 베링거 인겔하임 인터내셔날 게엠베하 경구 투여되는 다비가트란 제형의 제조 방법
EP2300431B1 (en) 2008-06-16 2016-01-06 Boehringer Ingelheim International GmbH Process for the manufacture of an intermediate in the synthesis of dabigatran
TWI436994B (zh) 2008-07-14 2014-05-11 Boehringer Ingelheim Int 製備含有達比加群(dabigatran)之藥物組合物的新穎方法
US8399678B2 (en) 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate

Also Published As

Publication number Publication date
PL2297132T3 (pl) 2015-07-31
CL2010001442A1 (es) 2011-05-13
AU2009259440A1 (en) 2009-12-23
NZ588488A (en) 2012-08-31
AR072143A1 (es) 2010-08-11
CN102066355B (zh) 2015-07-01
US8471033B2 (en) 2013-06-25
WO2009153215A1 (de) 2009-12-23
KR20110026412A (ko) 2011-03-15
AU2009259440B2 (en) 2014-05-29
EP2297132B1 (de) 2015-02-25
MX2010013258A (es) 2011-05-02
TWI440635B (zh) 2014-06-11
BRPI0914788A2 (pt) 2015-08-11
CA2728058A1 (en) 2009-12-23
RU2524212C2 (ru) 2014-07-27
KR101677915B1 (ko) 2016-11-21
CA2728058C (en) 2016-05-17
HUE025533T2 (en) 2016-05-30
JP5265003B2 (ja) 2013-08-14
EP2297132A1 (de) 2011-03-23
JP2011524403A (ja) 2011-09-01
RU2011101500A (ru) 2012-07-27
ES2536728T3 (es) 2015-05-28
TW201008925A (en) 2010-03-01
BRPI0914788B1 (pt) 2020-04-07
US20110118471A1 (en) 2011-05-19
IL208371A0 (en) 2010-12-30
CN102066355A (zh) 2011-05-18
IL208371A (en) 2014-11-30

Similar Documents

Publication Publication Date Title
DK2297132T3 (da) Fremgangsmåde til fremstilling af et mellemprodukt af dabigatran-etexilat
DK2501692T3 (da) Fremgangsmåde til fremstilling af dabigatranetexilat
LTPA2021002I1 (lt) Kvinolono junginių gamybos būdas
DK2144296T3 (da) Fremgangsmåde til fremstilling af et halvlederlag
DK2118090T3 (da) Fremgangsmåde til fremstilling af et benzimidazolderivat
DK2349132T3 (da) Apparat til behandling af gerd
DK2212070T3 (da) Fremgangsmåde til behandling af træ
DK2315750T3 (da) Forbedret fremgangsmåde til fremstilling af 2-trifluormethyl-5-(1-substituerede) alkylpyridiner
DK3412687T3 (da) Fremgangsmåder til behandling af dlbcl
DK2285779T3 (da) Fremgangsmåde til fremstilling af arylcarboxamider
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
DK2311970T3 (da) Fremgangsmåde til fremstillingen af bioprodukter
DK2382232T3 (da) Fremgangsmåde til fremstilling af bivalirudin
DK1884507T3 (da) Fremgangsmåde til fremstilling af glycerol
DK2185543T3 (da) Fremgangsmåde til optisk adskillelse af omeprazolsalte
DK2342346T3 (da) Thermotoga til behandling af biomasse
DK2326332T3 (da) Fremgangsmåde til behandling af sygdomme
DK2233011T3 (da) Fremgangsmåde til fremstilling af fermenteret mælk
DK2763981T3 (da) Fremgangsmåde til fremstilling af 1-(4-(4-(3,4-dichlor-2-fluorphenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-on-hydrochlorid og mellemprodukter anvendt deri
DK2251168T3 (da) Fremgangsmåde til fremstilling af træplader
DK2468877T3 (da) Fremgangsmåde til fremstilling af enzymer
DK2317877T3 (da) Fremgangsmåde til filtrering af mælk
DK2245001T3 (da) Fremgangsmåde til fremstilling af 2-fluoracyl-3-amino-acrylsyrederivater
DK2393795T3 (da) Fremgangsmåde til fremstilling af hydroxymethyldiphenyloxiraner og tilsvarende 1-azolylmethyl-1,2-diphenyloxiraner
DK2245000T3 (da) Fremgangsmåde til fremstilling af optisk aktive alfa-aminoacetaler